Connect Biopharma Holdings Limited (CNTB) Stock Overview
Explore Connect Biopharma Holdings Limited’s financial performance, market position, analyst ratings, and future outlook.
Connect Biopharma Holdings Limited (CNTB)
Key Financials
Key Financials
Market Cap
132.2M
P/E Ratio
-4.28
EPS (TTM)
$-0.61
ROE
-0.49%
CNTB Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Connect Biopharma Holdings Limited (NASDAQ: CNTB) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Connect Biopharma Holdings Limited's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of CNTB on the NASDAQ shows an RSI of 44.00, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $2.27 for the NASDAQ listing.
Key metrics behind Connect Biopharma Holdings Limited's NASDAQ-traded stock include a P/E ratio of -4.28 and a market capitalization of 132.2M. Combined with our AI analysis, these give both institutional and retail investors a clear view of CNTB on the NASDAQ.